Business Description
Calithera Biosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US13089P1012
Description
Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the United States. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.01 | |||||
| 9-Day RSI | 63.07 | |||||
| 14-Day RSI | 62.03 | |||||
| 6-1 Month Momentum % | -51.81 | |||||
| 12-1 Month Momentum % | -52.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | 0.03 | |||||
| EV-to-EBITDA | 0.03 | |||||
| Earnings Yield (Greenblatt) % | 3333.33 | |||||
| FCF Yield % | -22363.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CALA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Calithera Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -8.65 | ||
| Beta | -1.44 | ||
| Volatility % | 1722.86 | ||
| 14-Day RSI | 62.03 | ||
| 14-Day ATR ($) | 0.006365 | ||
| 20-Day SMA ($) | 0.025743 | ||
| 12-1 Month Momentum % | -52.61 | ||
| 52-Week Range ($) | 0.01 - 0.4999 | ||
| Shares Outstanding (Mil) | 4.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Calithera Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Calithera Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Calithera Biosciences Inc Frequently Asked Questions
What is Calithera Biosciences Inc(CALA)'s stock price today?
The current price of CALA is $0.04. The 52 week high of CALA is $0.50 and 52 week low is $0.01.
When is next earnings date of Calithera Biosciences Inc(CALA)?
The next earnings date of Calithera Biosciences Inc(CALA) is 2024-05-15 Est..
Does Calithera Biosciences Inc(CALA) pay dividends? If so, how much?
Calithera Biosciences Inc(CALA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers